(S)-4-Ethyl-4-hydroxy-7,8-dihydro-1H-pyrano[3,4-f]indolizine-3,6,10(4H)-trione-d5_product_DataBase

CAS: 1346617-23-9 F: C13H8D5NO5 W: 268.28

(S)-4-Ethyl-4-hydroxy-7,8-dihydro-1H-pyranoindolizine-3,6,10(4H)-trione-d5 is the deuterium labeled (S)-4-Ethyl-4-hydrox

This product is for research use only, not for human use. We do not sell to patients.

Bioactivity

(S)-4-Ethyl-4-hydroxy-7,8-dihydro-1H-pyrano[3,4-f]indolizine-3,6,10(4H)-trione-d5 is the deuterium labeled (S)-4-Ethyl-4-hydroxy-7,8-dihydro-1H-pyrano[3,4-f]indolizine-3,6,10(4H)-trione[1].

Invitro

Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[1].

Name

(S)-4-Ethyl-4-hydroxy-7,8-dihydro-1H-pyrano[3,4-f]indolizine-3,6,10(4H)-trione-d5

CAS

1346617-23-9

Formula

C13H8D5NO5

Molar Mass

268.28

Appearance

Solid

Transport

Room temperature in continental US; may vary elsewhere.

Storage

Powder	-20°C	3 years
	4°C	2 years
In solvent	-80°C	6 months
	-20°C	1 month

Reference

[1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-216.

PeptideDB

(S)-4-Ethyl-4-hydroxy-7,8-dihydro-1H-pyrano[3,4-f]indolizine-3,6,10(4H)-trione-d5

CAS: 1346617-23-9 F: C13H8D5NO5 W: 268.28